Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.